From 23 June 2025 weight loss injection treatment (Mounjaro) will be made available for eligible patients in primary care, under the NICE TA1026 guidance and NHS England’s phased rollout.
However, the NHS in Hampshire and the Isle of Wight (the local Integrated Care Board) have stated they will not be in a position to offer this service on prescription until later this year (autumn), in line with other regions where funding constraints and service setup are still being finalised. As such, we are unable to offer any Mounjaro prescriptions using these new criteria until further notice. Unfortunately, we do not have an exact date when it will become available.
When, in the future, we are able to offer Mounjaro for weight loss on prescription, the full qualifying criteria are as follows:
- BMI (Body Mass Index) of 40 or greater (37.5 for BAME individuals)
- Be enrolled in a structured diet and exercise programme
- Four or more of the following diagnosed health conditions:
Qualifying Conditions |
Definition |
Cardiovascular Disease |
Established atherosclerotic CVD (ischaemic heart disease, cerebrovascular disease, peripheral vascular disease, heart failure) |
Hypertension |
Established diagnosis of hypertension and requiring blood pressure lowering therapy |
Dyslipidaemia |
Treated with lipid-lowering therapy, or with low-density lipoprotein (LDL) ≥ 4.1 mmol/L, or high-density lipoprotein (HDL) <1.0 mmol/L for men or HDL<1.3 mmol/L for women, or fasting (where possible) triglycerides ≥1.7 mmol/L |
Obstructive Sleep Apnoea |
Established diagnosis of OSA (sleep clinic confirmation via sleep study) and treatment indicated i.e. meets criteria for continuous positive airway pressure (CPAP) or equivalent |
Type 2 Diabetes |
Established type 2 diabetes mellitus |
For more info visit: NHS weight loss support :: NHS Hampshire and Isle of Wight
If you’d like to explore your eligibility for NHS weight loss treatments or discuss private options, please contact us. The contact portal will open Monday to Friday 8 am to 6.30 pm.